Nephro Care India aims to raise Rs. 35-40 crore from its upcoming IPO

Nephro Care India, is planning to raise Rs. 35-40 crore through an initial public offering (IPO), subject to NSE emerge approval. This strategic move will allow Nephro Care to expand its operations across India.

The company plans to use the net proceeds from the IPO to establish a multi-speciality hospital named ‘Vivacity Multi Speciality Hospital’ in Madhyamgram, Kolkata, West Bengal. The remaining capital will be used for general corporate purposes. The new hospital, a unit of Nephro Care, will reportedly include 100 inpatient beds, including a 30-bed critical care unit with ICU, HDU, RTU, and NICU facilities. Vivacity will aim to offer treatment services in various disciplines, including cardiology, medical oncology, gastroenterology, gynecology, and an advanced renal transplant unit.

Key Highlights of the IPO

• Fresh Issuance: The IPO will consist of a fresh issuance of 45.84 lakh equity shares with a face value of Rs.10 each.

• Book Running Lead Manager: Corporate Capital Ventures is the Book Running Lead Manager, and Bigshare Services is the Registrar to the offer. Corporate Capital Ventures has a history of successful SME IPOs, including Trust Fintech, Creative Graphics, Alpex Solar, Esconet Technologies, Rockingdeals, Accent Microcell, Oriana Power, Droneacharya, and Crayons Advertising.
• Financial Performance: NCIL’s financial performance is on the rise. The company posted a revenue of Rs. 19.90 crore and a profit (PAT) of Rs. 3.4 crore in the first nine months of FY 2023-24, compared to a revenue of Rs. 17.09 crore and a profit (PAT) of Rs. 1.94 crore in FY 2022-23.

Founded in Kolkata in 2014 by Dr Pratim Sengupta, a leading nephrologist in India, Nephro Care aims to provide comprehensive medical services for kidney patients.